The invention relates to mutations in B-Raf gene products. The mutations described are identified in human tumours of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and the development of anti-cancer therapeutics.
申请公布号
WO03056036(A2)
申请公布日期
2003.07.10
申请号
WO2002GB05891
申请日期
2002.12.23
申请人
CATALYST BIOMEDICA LIMITED;STRATTON, MIKE;FUTREAL, ANDY;WOOSTER, RICHARD;MARAIS, RICHARD, MALCOLM;MARSHALL, CHRIS
发明人
STRATTON, MIKE;FUTREAL, ANDY;WOOSTER, RICHARD;MARAIS, RICHARD, MALCOLM;MARSHALL, CHRIS